Council for europe portal
Language : en Search
Choose language

European Pharmacopoeia Training Resources

In line with its commitment to providing clear and timely insight into its work and activities, the EDQM makes the resources of its  training sessions publicly available for the benefit of those stakeholders who could not attend in person.

24-25 May 2018, Zagreb, Croatia

EDQM Training session - Chemicals

Webinar on Raw Materials for the Production of Cell-based and Gene Therapy Medicinal Products (recorded on 09 November 2017)
Language: English - Duration: 1 hour, 30 minutes

The aim of this webinar is to explain the context of the elaboration of the new European Pharmacopoeia (Ph. Eur.) general chapter Raw materials of biological origin for the production of cell-based and gene therapy medicinal products and its scope. The first part of the webinar will give an introduction to the Ph. Eur. and its place within the EU regulatory network. The second part will be dedicated to the general chapter 5.2.12 and will provide information on the context of its elaboration followed by an overview of the chapter and the class of raw materials of biological origin covered. 

Register for FREE and receive the webinar recording

10-11 October 2017, Strasbourg, France

International Microbiology Symposium

11-12 July 2017, Strasbourg, France

EDQM Training session - Chemicals

Webinar on Elemental Impurities (recorded on 16 May 2017)
Language: English - Duration: 1 hour, 15 minutes

The ICH Q3D guideline represents a change of paradigm in the control of elemental impurities in medicinal products. This webinar covers how the implementation of ICH Q3D impacts on Ph. Eur. texts and on the assessment of CEP applications. The recording includes the Q&A session after the presentations.

7-8 February 2017, Strasbourg, France
European Pharmacopoeia training session on Biologicals

8 February 2017, Strasbourg, France
Joint EDQM-EMA Session on Biosimilars

Access the recorded presentations (video format)


6 December 2016, Strasbourg, France
European Pharmacopoeia Training Homoeopathic Products

7 July 2016, Strasbourg, France
Webinar on Call for experts

Webinar on Finished products monographs containing chemically defined substances in the Ph. Eur. (recorded 04 February 2016)

Language: English - Duration: 50 minutes

This webinar will give a general overview of the principles for finished product monographs with chemically defined active substances within the Ph. Eur., the content of these monographs and an update on the work programme. The monograph on Sitagliptin tablets (2927) will also be covered.

Webinar on Glass Containers for Pharmaceutical Use (General chapter 3.2.1) (recorded 10 December 2015)
Language: English - Duration: 1 hour, 10 minutes

This webinar will be in two parts. The first part will give a brief introduction to the Ph. Eur., some background into the history of this general chapter and highlight the changes that were introduced in Ph. Eur. (Supplement 8.3). The second part will focus on the revision of the chapter with an overview on hydrolytic resistance and delamination risk.

Webinar on Reverse osmosis in the Ph. Eur. monograph for Water for Injections (WFI) (recorded on 22 April 2015)
Language: English - Duration: 1 hour, 10 minutes

This webinar will start with a general introduction to the Ph. Eur. and the background of this history of water monographs. It will also give an overview of actions taken by the Ph. Eur. towards the revision of the WFI monograph, an update on the status of the revision of the WFI monograph and the consequences of the revision on other Ph. Eur. texts covering quality of water.

Webinar on Biologicals in the twenty-PhEur-st Century (recorded on 19 March 2015)
Language: English - Duration: 1 hour, 20 minutes

This webinar will give an overview of the main Ph. Eur. texts dealing with biologicals, with a specific focus on biotech products. It will also discuss the flexibility provided by the Ph. Eur. including examples of QbD approaches for biologicals and the role of the Ph. Eur. within the biosimilar context.


twitter facebook googleplus pinterest linkedin email